FBXW4

Across TCGA pan-cancer cohorts, FBXW4 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated FBXW4 data layer compared with 23 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher FBXW4 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated FBXW4 expression acts as an unfavorable survival marker, although some lineages such as GBM show a favorable association.

HNSC, LUAD, and GBM are the cancer types where FBXW4 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	IV	0.562	0.907	.005	7	view →
LUAD	DFS	Median	II,III,IV	0.432	0.711	.015	5	view →
GBM	OS	Quartile	All	0.601	0.429	.045	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

FBXW4–HNSC (OS)

Open the HNSC breakdown →